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Abstract
Background: Retrospective studies conducted in psychiatric wards have indicated a shorter duration of stay for
depressed inpatients in bright compared to dim daylight-exposed rooms, pointing to a possible antidepressant
effect of daylight conditions. Dynamic LED lighting, aiming to mimic daylight conditions, are currently been
installed in several hospitals, but their feasibility is poorly investigated.
Methods: To investigate the feasibility of these systems, we developed and installed a LED-lighting system in
four rooms in a psychiatric inpatient ward. The system could function statically or dynamically regarding light
intensity and colour temperature. The system consisted of (A) a large LED luminaire built into the window
jamb mimicking sunlight reflections, (B) two LED light luminaires in the ceiling and (C) a LED reading
luminaire. In the static mode, the systems provided constant light from A and B. In the dynamic mode, the
system changed light intensity and colour temperature using A, B and C. Patients with unipolar or bipolar
depression were randomised to dynamic or static LED lighting for 4 weeks, in addition to standard treatment.
Primary outcome was the rate of patients discontinuing the trial due to discomfort from the lighting
condition. Secondary outcomes were recruitment and dropout rates, visual comfort, depressive symptoms and
suicidal ideation.
Results: No participants discontinued due to discomfort from the LED lighting. Recruitment rate was 39.8%,
dropout from treatment rates were 56.3% in the dynamic group and 33.3% in the static group. 78.1% in the
dynamic group were satisfied with the lighting compared with 71.8% in the static group. Discomfort from the
light (glare) was reported by 11.5% in the dynamic group compared to 5.1% in the static group. Endpoint
suicidal scores were 16.8 (10.4) in the dynamic and 16.3 (14.9) in the static group. The lighting system was
100% functional. The light sensor system proved unstable.
Conclusion: Dropout from treatment was high primarily due to early discharge and with a lack of endpoint
assessments. The feasibility study has influenced an upcoming large-scale dynamic lighting efficacy trial where
we will use a shorter study period of 3 weeks and with more emphasis on endpoint assessments. The
lighting was well tolerated in both groups, but some found intensity too low in the evening. Thus, we will
use higher intensity blue-enriched light in the morning and higher intensity amber (blue-depleted) light in
the evening in the upcoming study. The light sensor system needs to be improved
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Background
The treatment of patients with severe depression,
whether as part of a unipolar or bipolar disorder, still
lacks efficacy. Patients are often discharged with residual
depressive symptoms [1] making them at risk of relapse
[2]. There has been no recent breakthrough in psycho-
pharmacology or psychotherapy, and new methods are
therefore needed. Chronotherapeutic treatments, includ-
ing bright light therapy, have shown promising prelim-
inary results in the treatment of both unipolar and
bipolar depression [3–7]. Some studies have included
both unipolar and bipolar depressed patients, but the re-
sults have not been reported separately, so we do not
know whether light therapy works best in bipolar or
unipolar depression. Light therapy has traditionally been
based on lightboxes used in the morning for 30–60 min
[8]. Light therapy seems to have relatively few adverse
effects [9], and with a good ocular safety [10], but it
probably has to be continued to maintain the anti-
depressant effect [11]. The recent discovery of the in-
trinsically photosensitive retinal ganglion cells (ipRGC)
[12], with peak sensitivity around 480 nm, and the devel-
opment of the light-emitting diode (LED) technology
have made it clinically relevant and possible to tailor
specific light intensities and spectral distributions
throughout the 24-h day. This technical development
has spurred an interest, in psychiatric settings, to move
from lightbox-administered light therapy towards using
integrated LED-lighting systems exposing patients to dy-
namic light therapy throughout the day. A few retro-
spective cohort studies based on daylight or LED light
at inpatient wards have been carried out showing a
shortened length of inpatient stay with brighter condi-
tions [13–16]. Our group has recently investigated the
impact of daylight in psychiatric inpatients and found a
shorter stay in rooms located on the brighter south-east
side of the building compared to rooms on the dimmer
north-west side [17]. A recent randomised trial in post-
stroke patients showed a strengthening of melatonin
rhythmicity and improved mood with brighter light con-
ditions [18, 19].
Currently, dynamic LED lighting is increasingly being
installed in hospital settings attempting to mimic
daylight conditions with temporally regulated intensity
and spectral distribution. The aim is to strengthen
circadian entrainment to stabilise the sleep-wake cycle,
provide alertness and increase the antidepressant effect.
However, the usability, acceptability, adverse effects
and efficacy of these systems are poorly investigated.
This study aims to investigate the feasibility of a dynamic
versus a static lighting condition delivered to patients with
depressive disorders as a pre-study to a planned larger effi-
cacy study with dynamic lighting. In this study, we chose to
include both patients with unipolar and bipolar depression
because we wanted to know whether patients with bipolar
depression would switch to a hypomanic or manic state.
We also generally need more data on light treatment in
bipolar patients as this condition has been studied less than
unipolar depression.
Methods
We developed a new general lighting system using dy-
namic LED lighting installed in four single-bed patient
rooms in a psychiatric inpatient ward. The system con-
sisted of (A) a large LED panel built into the window
jamb to mimic sunlight reflections, (B) two dynamic
LED light fixtures in the ceiling and (C) one dynamic
LED reading luminaire by the bed. Patients with a
current depressive episode as part of a unipolar or a bi-
polar depression were randomised, in a 3:2 manner to
either dynamic LED-lighting intervention (dynamic) or
static LED-lighting intervention (static), for 4 weeks in
addition to standard treatment. The randomisation was
done automatically within the OpenClinica electronic
Case Report Form (eCRF) system after entering of all eli-
gibility criteria, and randomisation was thus concealed
from investigators. The OpenClinica eCRf system was
operated by the Copenhagen Trial Unit (CTU). We
opted for 15 participants as we anticipated that this
number would give indications of major problems with
the lighting system, trial design, and adverse events. The
randomisation with more participants into the dynamic
group was chosen to increase the likelihood of finding
serious adverse events in this group where we expected
that the brighter light and a luminaire that could not be
turned off might cause problems for the participants.
Participant selection
The screening was done at the inpatient ward. Diagnoses
were assessed by the Mini International Neuropsychiatric
Interview (M.I.N.I.) [20]. Inpatients were consecutively
asked to partake in the study. Inclusion criteria were age
> 18 years, a major depressive episode as part of a unipolar
or bipolar disorder according to the Diagnostic and
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Statistical Manual version IV (DSM-IV) [21], informed
consent and speaks and understands the Danish language.
Exclusion criteria were severe suicidality corresponding to
a score > 2 on Hamilton depression rating scale item 3 or
if the investigators were unsure of the degree of suicidality,
current psychotic symptoms at time of inclusion, Young
Mania Rating Scale (YMRS) > 7, fulfilling DSM-IV criteria
for a current hypomanic or manic episode, or mandatory
psychiatric treatment of any kind.
Experimental protocol
The study was approved by the Regional Committee on
Health Research Ethics (J.nr. H-17010932) and the Da-
nish Data Protection Agency (j.nr.: VD-2018-515). Par-
ticipants were assessed psychometrically weekly. All four
rooms could be switched to either dynamic or static
mode through a centrally placed control panel. All par-
ticipants signed informed consent forms before enroll-
ment into the study. The CONSORT flow diagram is
show below in Fig. 1.
Light intervention
The dynamic intervention setup consisted of three lighting
elements (A, B and C). A was an LED luminaire built into
the window jamb mimicking the natural sunlight (see Fig. 2).
It was scheduled to turn on at 06:00 till 18:00 in the summer
period (from February 14 to October 31) and from 07:00 till
17:00 in the winter period (from November 1 to February
14). The light from this luminaire varied continuously in
Correlated Colour Temperature (CCT) from 1800K dim,
warm light at dawn rising to 5500K bright white light from
9:00 to 14:00. From 14:00 and onward, the light from the lu-
minaire was reduced in both intensity and CCT. The LED
luminaire (A) could not be controlled by the participants,
but a semi-translucent curtain could be drawn to reduce in-
tensity. The panel contained cool white (CW), warm white
(WW) and wide-spectrum amber (Amber) LEDs. B was two
circular luminaires containing CW/WW/Amber LEDs
mounted in the ceiling with dynamic regulation of intensity
and CCT during the whole 24-h day. The light varied from
1800K dim, warm light to 4000K at a maximum intensity
Fig. 1 Consort flow diagram
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brighter than usual in a patient room. The ceiling luminaires
could be turned off/on by the participants as preferred. Dur-
ing the summer, the dynamic LED lighting was brightest be-
tween 09:00 and 14:00 and dimmest and warmest from 23:
00 to 06:00. In the winter period, the timings were changed
from 09:30 to 13:30 and from 22:30 to 07:00, respectively.
C was a reading luminaire by the bed, with similar de-
sign and timing as the ceiling lighting and regulation of
CCT from 1800 to 4000 K, also containing CW/WW/
Amber LEDs. The intensity of the reading luminaire was
kept relatively low yet permitting reading. Like the ceil-
ing luminaire, the reading luminaire could be turned off/
on by the participants as preferred. All transitions in A,
B and C were made as slow, continuous fades to mimic
the nature of daylight. If turned on during nighttime, the
ceiling (B) and reading luminaires (C) gave a dim level
Amber light. If turned off, The A, B and C luminaire
started automatically in the morning with dim Amber
light. In emergency situations, the dynamic regulation
could be overridden to the standard (static) regime by a
3-s push on the switch.
Figure 2 shows the light installation in a patient room
with the dynamic setup turned on. The window lumin-
aire is seen built into the righthand window jamb and
one on the ceiling, and the reading luminaire is also
visible.
The static intervention used the same luminaires as
the dynamic intervention but was completely static with
regards to intensity, CCT and timing. The window jamb
luminaire (A) was turned off, and the ceiling luminaire
(B) and reading luminaire (C) were both set to 3000 K,
with an intensity expected in a standard patient room.
Both ceiling (B) and reading luminaires (C) could be
turned on/off as preferred by the participants. The use
of ceiling and reading luminaire was logged continuously
by the computer regulating the lighting system in both
groups. All participants were offered psychopharmaco-
logical, psychotherapeutic and other treatments as usual.
Patients were informed that the trial tested two different
lighting systems to evaluate visual comfort, lighting
system performance and any influence on depressive
symptoms. They were also informed that the window lu-
minaire was not active in the static group. Participant
were informed that it was not known a priory what
setup would be best. Participants were thus not blinded
to the intervention.
Outcomes
The primary outcome was the rate of participants dis-
continuing the trial due to discomfort from the lighting
conditions. Secondary outcomes were recruitment rate,
dropout rate, visual comfort, level of depressive symp-
toms and suicidal ideation. The primary outcome was
chosen because we were uncertain on how patients
would react to a built-in luminaire with higher than
usual intensity and a window luminaire that could not
be turned off. This information is considered of major
importance regarding the upcoming efficacy trial. The
secondary outcomes were chosen as feasibility (dropout,
visual comfort) and safety measures (suicidal ideation
and depressive symptoms) and to inform about dimen-
sioning of the upcoming efficacy trial regarding the
number of rooms with light installation and trial length
(recruitment flow).
Explorative outcomes were manic symptoms, self-
assessed depression symptoms, quality of life, sleep, adverse
effect, chronotype, room occupancy, use of luminaires, light
intensity and spectral intensity, and medication. Hamilton
rating was done by an experienced research coordinator
that were blinded for treatment allocation and who did not
have any other association with the study procedures.
Outcome measures
Visual comfort was assessed by a newly designed Visual
Comfort Scale, depression severity by the Hamilton De-
pression Rating Scale (HAM-D17) [22], and suicidal idea-
tion by the Suicidal Ideation Attribution Scale (SIDAS)
[23]. Manic symptoms were assessed by the Young Mania
Rating Scale (YMRS) [24], self-assessed depression level by
the Major Depression Inventory (MDI) [25], quality of life
Fig. 2 Light installation in a single-bed patient room with light in
dynamic mode
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by the WHO-5 well-being index [26], sleep by the Pitts-
burg Sleep Quality Index (PSQI) [27] and from a diary with
sleep onset and offset, naps, sleep quality and awakening.
Adverse effect were assessed by the UKU (Udvalget for Kli-
niske Undersøgelser) adverse event scale [28], and chrono-
type by the Morningness-Eveningness Scale (MEQ) [29],
and room occupancy from a diary estimating hours spent
in the room during daytime. The use of ceiling luminaires
and reading luminaires was registered (logged by the light-
ing computer system) throughout the study for both treat-
ment conditions. Light sensors were mounted in each
room, one at the window pointing outwards and two in
the room, all measuring the intensity and spectral distribu-
tion. Medication was recorded from case files at baseline.
Results
Sociodemographics
Participants were recruited from December 12, 2017, to
December 19, 2018. Participants had a median age [range]
of 36.0 [26–56]/59.0 [34–70] years in the dynamic/static
group with 66.7% females and 33.3% males in both groups.
Median number (interquartile range IQR) of previous de-
pressive episodes was 1.0 (0–2.0)/1.5 (0.5–19.0), and me-
dian duration of current depressive episode was 1.8 (1.0–
8.5)/13.0 (4–41) months. In all, 20% (n = 3) of participants
had a depressive episode as part of a bipolar disorder, see
Table 1 for sociodemographic data.
Primary and secondary outcomes
Nine participants were randomised to the dynamic group
and six to the static group in the period from December 12,
2017, to December 19, 2018. No participants discontinued
the trial due to discomfort from the lighting condition.
Recruitment rate was only 39.5% (15/38). Recruitment rate
was low due to long staying non-eligible patients in one of
the four test rooms. Dropout rates from treatment at week
four were 55.6% (five out of nine) in the dynamic and
33.3% (two out of six) in the static group, primarily caused
by early discharge (n = 6). Visual comfort results are shown
in Table 2. Participants in the static group reported that
they used the ceiling and bed luminaires to a higher degree
in the morning and afternoon than the participants in the
dynamic group. More glares were reported from the ceiling
and reading luminaire in the dynamic group. Participants
in both groups reported low satisfaction with the reading
luminaires in the evening due to too low light intensity
making reading difficult. Finally, some participants reported
glare from the window jamb luminaire in the morning.
General satisfaction with the lighting (Question 3c) was
78.1% in the dynamic group versus 71.8% in the static
group. The HAM-D17 scale showed moderate depression
levels at baseline without any difference between groups
during the 4-week period. The SIDAS scale showed low to
moderate degrees of suicidal ideation in both groups with
baseline SIDAS scores in the dynamic/static group of 15.5
(SD = 6.8)/16.6 (SD = 11.7) and endpoint scores of 16.8
(SD = 10.4)/16.3 at (SD = 14.9) (n = 4/4).
Exploratory outcome measures
The mean YMRS scores were low with baseline scores of
2.2 (SD = 3.4)/0 (SD = 0) (n = 9/6) in the dynamic/static
groups and endpoint scores of 0 (SD = 0)/0.5 (SD = 1.0) (n
= 4/4). The baseline MDI scores in the dynamic/static
groups were 29.4 (SD = 12.8)/28.0 (SD = 15.4) (n = 5/8),
and endpoint scores were 18.8 (SD = 10.9)/27.8 (SD = 13.6)
(n = 4/4). The baseline WHO-5 scores (highest = best) in
the dynamic/static groups were 29.5 (SD = 24.2)/21.6 (SD =
8.3) (n = 8/5) and endpoint scores were 40.0 (SD = 27.9)/
37.0 (SD = 31.7 (n = 4/4). Adverse events from the UKU
scale were few, including low levels of headache and light
sensitivity. One participant in the dynamic group had a
non-serious self-harm episode, and another participant in
the dynamic group, when on leave, took an overdose of
medication with no complications. The last incident was
reported to the research ethics committee. Neither of the
incidents was considered related to the LED lighting.
Table 1 Sociodemographics
Parameter Static LED-lighting group Dynamic LED-lighting group
Participants (number of participants (percentage)) 6 (40.0%) 9 (60.0%)
Gender (female/male) (number of participants (percentage)) 4/2 (66.7%/33.3%) 6/3 (66.7%/33.3%)
Smoking (number of participants (percentage)) 4/5 (80.0%) 3/8 (37.5%)
Self-perceived as a light sensitive person (number of participants (percentage)) 2/5 (40.0%) 3/8 (37.5%)
Migraine illness (number of participants (percentage)) 1/5 (20.0%) 0/8 (0%)
Eliciting factor for current depressive episode (number of participants (percentage)) 3/5 (60.0%) 5/8 (62.5%)
Suicide attempt in current depressive episode (number of participants (percentage)) 2/5 (40.0%) 1/8 (12.5%)
Age, years (median (IQR)) 59.0 (34–70) 36.0 (26–56)
Number of previous depressive episodes (median (IQR)) 1.5 (0.5–19.0) 1.0 (0–2.0)
Duration (months) of actual depressive episode (median (IQR)) 13.0 (4–41) 1.8 (1.0–8.5)
IQR interquartile range
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Mean sleep onset, in the dynamic/static group, was 23:
25 (SD = 41min)/23:02 (SD = 52min) during week 1
(mean of 7 days) and 23:59 (SD = 89min)/23:29 (SD = 50
min) during week 4. Mean sleep offset in the dynamic/
static groups was 6:45 (SD = 131min)/7:18 (SD = 60min)
during week 1 and 7:46 (SD = 129min)/7:16 (SD = 56
min) during week 4. Mean subjective sleep quality in the
dynamic/static group (0–10, 10 best) was 6.5 (SD = 3.1)/
6.2 (SD = 2.6) during week 1 and 7.1 (SD = 2.5)/5.2 (SD =
2.0) during week 4. There was no difference between
groups in number of awakenings. Mean PSQI global
scores in the dynamic/static groups (lower score = best)
was 10.6 (SD = 5.2)/8.4 (SD = 5.7) at baseline and 9.0 (SD
= 7.0)/13.3 (SD = 2.2) at endpoint. Mean MEQ scores
showed participants to be intermediate chronotypes with
baseline scores in the dynamic/static groups of 48.8 (SD =
7.6)/46.2(SD = 12.0) and endpoint scores of 46.0 (SD =
8.0)/49.8 (SD = 9.2). The room occupancy diary showed
that participants, during the 4 weeks period, were in their
room in the dynamic/static group for 2.3 (SD = 1.5)/2.3
(SD = 1.4) hours in the morning, 2.6 (SD = 1.7)/3.3 (SD =
1.8) hours in the afternoon and 2.2 (SD = 1.6)/3.1 (SD =
3.8) hours in the evening, summing up to 7.1 (SD = 4.1)/
8.7 (SD = 3.8) hours in total. Nearly all participants used
their curtains at some time of the day (100%/93.3%). How-
ever, only 15.8% used curtains all day in the dynamic
group compared to 35.7% in the static group.
Luminaire log data were available for five participants
in the dynamic group and four participants in the static
group. The mean daytime use of the ceiling luminaires
in the dynamic/static groups (07:00–23:00) was 9.2 (SD
= 5.8)/3:6 (SD = 4.4) hours with a distribution of 33.3%/
35.9% in the morning (7:00–12:00), 34.2%/31.8% in the
afternoon (12:00–18:00) and 32.4%/32.2% in the evening
(18:00–23:00). The mean nighttime (23:00–7:00) use of
the ceiling luminaires in the dynamic/static groups was
81.9 (SD = 96.8)/0.7 (SD = 4.9) minutes. The mean day-
time use of the reading luminaires in the dynamic/static
group was 9.2 (SD = 5.4)/5.2 (SD = 4.5) hours, with a
distribution of 31.0%/28.2% in the morning, 31.9%/24.6%
in the afternoon and 37.2%/47.2% in the evening. The
mean nighttime use of the reading luminaires in the dy-
namic/static groups was 86.7 (SD = 96.7)/33.5 (SD =
76.0) minutes. The LED-lighting system was 100% reli-
able. One participant experienced a 3-hour dark-out
of the system due to a general electrical malfunction
at the hospital. The light sensor system had too low
sensitivity to measure the spectral distribution of
room light reliable. Case files showed that participants
in both groups were treated with antidepressants,
mood stabilisers, antipsychotics, anxiolytics and sleep-
ing medications.
Figure 3 shows an example of temporal melanopic
irradiance (according to the CIE S026) measurements
from a single day. The blue line is irradiance from the
window daylight sensor pointing outwards. The red line is
from the room sensor placed above the bed, and the yel-
low line is from the room sensor placed opposite the bed.
Discussion
It was possible to evaluate the feasibility of the LED
lighting system and the study design. In this study, we
chose the rate of discontinuation as the primary out-
come because we were unsure of how patients would
Fig. 3 Measurement of melanopic irradiances from a sensor in the window pointing outwards (blue), a sensor above the bed (red) and a sensor
opposite the bed (yellow), over a single day
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react to having light treatment built into their room. We
feared that too high light intensity or glare would make
patients leave their room, and we also were unsure how
patients would react to the dynamic luminaire built into
the window jamb that they could not turn off. However,
the results showed no discontinuation due to discomfort
from the lighting system, and the satisfaction with the
dynamic system was equal or higher than with the static
system. There were a low recruitment rate and large at-
trition rate, especially at week four. Most participants in
both groups were satisfied with the lighting system.
Depressive symptoms were moderate at baseline. The
high dropout from treatment at endpoint made out-
comes difficult to interpret. The high dropout was pri-
marily due to early discharge. There was a moderate
degree of suicidal ideation in both groups.
Methodological strengths include a randomised design,
reaching the sample size, a detailed assessment of feasi-
bility measures and functionality of the lighting system.
Methodological limitations include a low sample size
with an inherently large risk of type II errors, large
dropout and a malfunctioning lighting sensor system.
The imbalance between groups in the mean length of
current depressive episodes is likely an artefact of the
low sample size.
Conclusion
A larger number of light-equipped rooms would help at-
tain a higher number of recruitments per month, making
larger trials more feasible. The study period should be
shortened to reduce dropout due to early discharge. The
most important is to secure an endpoint assessment,
even if the participants drop out due to early discharge
or for other reasons. It may induce bias if trial partici-
pants are not assessed at follow-up, and we should aim
at a 95% completion rate. This completion rate might be
accomplished by informing in the oral presentation and
in the written material that an endpoint assessment is
important even if the participant is discharged. The vis-
ual comfort data indicated that light intensity was too
low in the evening, and pointing to that in future trials,
intensity of light can be increased. Higher light intensity
should, however, contain very little blue light to avoid
undue melatonin suppression that would disturb sleep.
The light sensor system should be replaced with more
sensitive and stable sensors. The study did show that it
was possible to make a detailed assessment of patients
regarding feasibility and depression and sleep outcomes.
The study shows the importance of carrying out a feasi-
bility trial to test the design and technical systems and
to evaluate lighting tolerability. We are looking forward
to implementing these results in a randomised clinical
efficacy trial with dynamic LED lighting.
This efficacy trial (now running) has ten rooms (out of
12 rooms) installed with a similar lighting system in a
similar ward. We believe this will increase the number of
inclusions. The efficacy trial aims at a total of 150 patients,
with 75 in each group. This larger sample will increase the
power to detect clinically meaningful differences between
groups. We have decided to reduce the trial length from 4
to 3 weeks, thus reducing attrition due to early discharge.
Furthermore, we have implemented a mandatory endpoint
assessment at week 3 for all included patients even if they
are discharged early or if the intervention is stopped for
other reasons.
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